東銀國際控股(00668.HK)中期純利升3.48%至2456.5萬港元
格隆匯 8 月 5日丨東銀國際控股(00668.HK)發佈中期業績,截至2020年6月30日止中期,公司實現收益1580.9萬港元,同比減少4.29%;公司擁有人應占溢利約2456.5萬港元,同比增長3.48%;每股基本盈利1.93港仙;不派息。
公告稱,溢利增加主要由於2020年上半年透過財務收入淨額產生了約4,190萬港元的收益。2020年上半年出現約440萬港元匯兑虧損,而2019年上半年並無重大的匯兑虧損。另外,2020年上半年透過損益按公平值列賬之財務資產產生了約180萬港元的虧損及購買花卉及植物成本增多了約640萬港元,相反2019年上半年並沒有成本支出。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.